Physical activity and exertional desaturation are associated with mortality in idiopathic pulmonary fibrosis

Journal of Clinical Medicine

Volumn 5, Issue 8, 2016, Pages

  Vainshelboim, Baruch ^a,b,c   Reuven, Mordechai ^a,d   Izhakian, Shimon ^a   Lima, Ricardo M ^c,e   Oliveira, Jose ^b  

^a RABIN MEDICAL CENTER   (Israel)

^b UNIVERSITY OF PORTO   (Portugal)

^c VA PALO ALTO HEALTH CARE SYSTEM   (United States)

^d TEL AVIV UNIVERSITY   (Israel)

^e UNIVERSITY OF BRASILIA   (Brazil)

Author keywords

Exercise; Inactivity; International physical activity questionnaire; Interstitial lung disease; Pulmonary rehabilitation

Indexed keywords

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL PRACTICE; CLINICAL TRIAL; EXERTIONAL DESATURATION; FEMALE; FIBROSING ALVEOLITIS; FOLLOW UP; HUMAN; HYPOXEMIA; INTERNATIONAL PHYSICAL ACTIVITY QUESTIONNAIRE; LUNG FUNCTION TEST; LUNG TRANSPLANTATION; MALE; METABOLIC EQUIVALENT; MORTALITY; OBSERVATIONAL STUDY; OXYGEN DESATURATION; OXYGEN THERAPY; PHYSICAL ACTIVITY; PHYSICAL INACTIVITY; PREDICTION; PROGNOSIS; PROSPECTIVE STUDY; PULMONARY REHABILITATION; QUESTIONNAIRE; SIX MINUTE WALK TEST; SURVIVAL RATE;

EID: 85114276676     PISSN: None     EISSN: 20770383     Source Type: Journal    
DOI: 10.3390/jcm5080073     Document Type: Article

References (54)

1. Raghu, G.; Collard, H.R.; Egan, J.J.; Martinez, F.J.; Behr, J.; Brown, K.K.; Colby, T.V.; Cordier, J.F.; Flaherty, K.R.; Lasky, J.A.; et al. An official ATS/ERS/JRS/ALAT statement: Idiopathic pulmonary fibrosis: Evidence-based guidelines for diagnosis and management. Am. J. Respir. Crit. Care Med. 2011, 183, 788–824.
2. Olson, A.L.; Swigris, J.J.; Lezotte, D.C.; Norris, J.M.; Wilson, C.G.; Brown, K.K. Mortality from pulmonary fibrosis increased in the United States from 1992 to 2003. Am. J. Respir. Crit. Care Med. 2007, 176, 277–284.
3. Meltzer, E.B.; Noble, P.W. Idiopathic pulmonary fibrosis. Orphanet J. Rare Dis. 2008, 3, 8.
4. Lama, V.N.; Flaherty, K.R.; Toews, G.B.; Colby, T.V.; Travis, W.D.; Long, Q.; Murray, S.; Kazerooni, E.A.; Gross, B.H.; Lynch, J.P. 3rd; et al. Prognostic value of desaturation during a 6-min walk test in idiopathic interstitial pneumonia. Am. J. Respir. Crit. Care Med. 2003, 168, 1084–1090.
5. Swigris, J.J.; Brown, K.K.; Make, B.J.; Wamboldt, F.S. Pulmonary rehabilitation in idiopathic pulmonary fibrosis: A call for continued investigation. Respir. Med. 2008, 102, 1675–1680.
6. Wallaert, B.; Monge, E.; Le Rouzic, O.; Wemeau-Stervinou, L.; Salleron, J.; Grosbois, J.M. Physical activity in daily life of patients with fibrotic idiopathic interstitial pneumonia. Chest 2013, 144, 1652–1658.
7. World Health Organization. Global Recommendations on Physical Activity for Health;World Health Organization: Geneva, Switzerland, 2010.
8. Hallal, P.C.; Andersen, L.B.; Bull, F.C.; Guthold, R.; Haskell, W.; Ekelund, U.; Lancet Physical Activity Series Working Group. Global physical activity levels: Surveillance progress, pitfalls, and prospects. Lancet 2012, 380, 247–257.
9. Lee, I.M.; Shiroma, E.J.; Lobelo, F.; Puska, P.; Blair, S.N.; Katzmarzyk, P.T.; Lancet Physical Activity Series Working Group. Effect of physical inactivity on major non-communicable diseases worldwide: An analysis of burden of disease and life expectancy. Lancet 2012, 380, 219–229.
10. Spruit, M.A.; Singh, S.J.; Garvey, C.; Zuwallack, R.; Nici, L.; Rochester, C.; Hill, K.; Holland, A.E.; Lareau, S.C.; Man, W.D.; et al. An official american thoracic society/european respiratory society statement: Key concepts and advances in pulmonary rehabilitation. Am. J. Respir. Crit. Care Med. 2013, 188, e13–e64.
11. Nakayama, M.; Bando, M.; Araki, K.; Sekine, T.; Kurosaki, F.; Sawata, T.; Nakazawa, S.; Mato, N.; Yamasawa, H.; Sugiyama, Y. Physical activity in patients with idiopathic pulmonary fibrosis. Respirology 2015, 20, 640–646.
12. Leuchte, H.H.; Mernitz, P.; Baezner, C.; Baumgartner, R.A.; von Wulffen, W.; Neurohr, C.; Behr, J. Self-Report Daily Life Activity as a Prognostic Marker of Idiopathic Pulmonary Fibrosis. Respiration 2015, 90, 460–467.
13. Bouchard, C.; Blair, S.N.; Katzmarzyk, P.T. Less Sitting, More Physical Activity, or Higher Fitness? Mayo Clin. Proc. 2015, 90, 1533–1540.
14. Watz, H.; Pitta, F.; Rochester, C.L.; Garcia-Aymerich, J.; ZuWallack, R.; Troosters, T.; Vaes, A.W.; Puhan, M.A.; Jehn, M.; Polkey, M.I.; et al. An official European Respiratory Society statement on physical activity in COPD. Eur. Respir. J. 2014, 44, 1521–1537.
15. Vainshelboim, B.; Oliveira, J.; Yehoshua, L.; Weiss, I.; Fox, B.D.; Fruchter, O.; Kramer, M.R. Exercise Training-Based Pulmonary Rehabilitation Program Is Clinically Beneficial for Idiopathic Pulmonary Fibrosis. Respiration 2014, 88, 378–388.
16. Florey, C.D. Sample size for beginners. BMJ 1993, 306, 1181–1184.
17. Holland, A.E.; Hill, C.J.; Conron, M.; Munro, P.; McDonald, C.F. Short term improvement in exercise capacity and symptoms following exercise training in interstitial lung disease. Thorax 2008, 63, 549–554.
18. Vainshelboim, B.; Oliveira, J.; Fox, B.D.; Soreck, Y.; Fruchter, O.; Kramer, M.R. Long-term effects of a 12-week exercise training program on clinical outcomes in idiopathic pulmonary fibrosis. Lung 2015, 193, 345–354.
19. Vainshelboim, B.; Oliveira, J.; Fox, B.D.; Kramer, M.R. The Prognostic Role of Ventilatory Inefficiency and Exercise Capacity in Idiopathic Pulmonary Fibrosis. Respir. Care 2016, 61, 1100–1109.
20. Mahler, D.A.; Wells, C.K. Evaluation of clinical methods for rating dyspnea. Chest 1988, 93, 580–586.
21. Papiris, S.A.; Daniil, Z.D.; Malagari, K.; Kapotsis, G.E.; Sotiropoulou, C.; Milic-Emili, J.; Roussos, C. The Medical Research Council dyspnea scale in the estimation of disease severity in idiopathic pulmonary fibrosis. Respir. Med. 2005, 99, 755–761.
22. Craig, C.L.; Marshall, A.L.; Sjostrom, M.; Bauman, A.E.; Booth, M.L.; Ainsworth, B.E.; Pratt, M.; Ekelund, U.; Yngve, A.; Sallis, J.F.; et al. International physical activity questionnaire: 12-Country reliability and validity. Med. Sci. Sports Exerc. 2003, 35, 1381–1395.
23. Booth, M. Assessment of physical activity: An international perspective. Res. Q. Exerc. Sport 2000, 71 (Suppl. S2), S114–S120.
24. Lee, P.H.; Macfarlane, D.J.; Lam, T.H.; Stewart, S.M. Validity of the International Physical Activity Questionnaire Short Form (IPAQ-SF): A systematic review. Int. J. Behav. Nutr. Phys. Act. 2011, 8.
25. Garber, C.E.; Blissmer, B.; Deschenes, M.R.; Franklin, B.A.; Lamonte, M.J.; Lee, I.M.; Nieman, D.C.; Swain, D.P.; American College of Sports Medicine. American College of Sports Medicine position stand. Quantity and quality of exercise for developing and maintaining cardiorespiratory, musculoskeletal, and neuromotor fitness in apparently healthy adults: Guidance for prescribing exercise. Med. Sci. Sports Exerc. 2011, 43, 1334–1359.
26. Pescatello, L.S.; American College of Sports Medicine. ACSM’s Guidelines for Exercise Testing and Prescription, 9th ed.;Wolters Kluwer/Lippincott Williams & Wilkins Health: Philadelphia, PA, USA, 2014.
27. Haskell, W.L.; Lee, I.M.; Pate, R.R.; Powell, K.E.; Blair, S.N.; Franklin, B.A.; Macera, C.A.; Heath, G.W.; Thompson, P.D.; Bauman, A.; et al. Physical activity and public health: Updated recommendation for adults from the American College of Sports Medicine and the American Heart Association. Circulation 2007, 116, 1081–1093.
28. Pate, R.R.; Pratt, M.; Blair, S.N.; Haskell, W.L.; Macera, C.A.; Bouchard, C.; Buchner, D.; Ettinger, W.; Heath, G.W.; King, A.C.; et al. Physical activity and public health. A recommendation from the Centers for Disease Control and Prevention and the American College of Sports Medicine. JAMA 1995, 273, 402–407.
29. ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories. ATS statement: Guidelines for the six-minute walk test. Am. J. Respir. Crit. Care Med. 2002, 166, 111–117.
30. Macintyre, N.; Crapo, R.O.; Viegi, G.; Johnson, D.C.; van der Grinten, C.P.; Brusasco, V.; Burgos, F.; Casaburi, R.; Coates, A.; Enright, P.; et al. Standardisation of the single-breath determination of carbon monoxide uptake in the lung. Eur. Respir. J. 2005, 26, 720–735.
31. Miller, M.R.; Crapo, R.; Hankinson, J.; Brusasco, V.; Burgos, F.; Casaburi, R.; Coates, A.; Enright, P.; van der Grinten, C.P.; Gustafsson, P.; et al. General considerations for lung function testing. Eur. Respir. J. 2005, 26, 153–161.
32. Wanger, J.; Clausen, J.L.; Coates, A.; Pedersen, O.F.; Brusasco, V.; Burgos, F.; Casaburi, R.; Crapo, R.; Enright, P.; van der Grinten, C.P.; et al. Standardisation of the measurement of lung volumes. Eur. Respir. J. 2005, 26, 511–522.
33. Quanjer, P.H.; Tammeling, G.J.; Cotes, J.E.; Pedersen, O.F.; Peslin, R.; Yernault, J.C. Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. Eur. Respir. J. Suppl. 1993, 16, 5–40.
34. Mura, M.; Porretta, M.A.; Bargagli, E.; Sergiacomi, G.; Zompatori, M.; Sverzellati, N.; Taglieri, A.; Mezzasalma, F.; Rottoli, P.; Saltini, C.; et al. Predicting survival in newly diagnosed idiopathic pulmonary fibrosis: A 3-year prospective study. Eur. Respir. J. 2012, 40, 101–109.
35. Wallaert, B.; Guetta, A.; Wemeau-Stervinou, L.; Terce, G.; Valette, M.; Neviere, R.; Aguilaniu, B. [Prognostic value of clinical exercise testing in idiopathic pulmonary fibrosis]. Rev. Mal. Respir. 2011, 28, 290–296.
36. Mukaka, M.M. Statistics corner: A guide to appropriate use of correlation coefficient in medical research. Malawi Med. J. 2012, 24, 69–71.
37. du Bois, R.M.; Albera, C.; Bradford, W.Z.; Costabel, U.; Leff, J.A.; Noble, P.W.; Sahn, S.A.; Valeyre, D.; Weycker, D.; King, T.E., Jr. 6-Min walk distance is an independent predictor of mortality in patients with idiopathic pulmonary fibrosis. Eur. Respir. J. 2014, 43, 1421–1429.
38. Caminati, A.; Bianchi, A.; Cassandro, R.; Mirenda, M.R.; Harari, S.Walking distance on 6-MWT is a prognostic factor in idiopathic pulmonary fibrosis. Respir. Med. 2009, 103, 117–123.
39. Lederer, D.J.; Arcasoy, S.M.; Wilt, J.S.; D’Ovidio, F.; Sonett, J.R.; Kawut, S.M. Six-minute-walk distance predicts waiting list survival in idiopathic pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 2006, 174, 659–664.
40. Lee, D.C.; Pate, R.R.; Lavie, C.J.; Sui, X.; Church, T.S.; Blair, S.N. Leisure-time running reduces all-cause and cardiovascular mortality risk. J. Am. Coll. Cardiol. 2014, 64, 472–481.
41. Tudor-Locke, C.; Craig, C.L.; Aoyagi, Y.; Bell, R.C.; Croteau, K.A.; De Bourdeaudhuij, I.; Ewald, B.; Gardner, A.W.; Hatano, Y.; Lutes, L.D.; et al. How many steps/day are enough? For older adults and special populations. Int. J. Behav. Nutr. Phys. Act. 2011, 8, 80.
42. Flaherty, K.R.; Andrei, A.C.; Murray, S.; Fraley, C.; Colby, T.V.; Travis, W.D.; Lama, V.; Kazerooni, E.A.; Gross, B.H.; Toews, G.B.; et al. Idiopathic pulmonary fibrosis: Prognostic value of changes in physiology and six-minute-walk test. Am. J. Respir. Crit. Care Med. 2006, 174, 803–809.
43. Nelson, M.E.; Rejeski, W.J.; Blair, S.N.; Duncan, P.W.; Judge, J.O.; King, A.C.; Macera, C.A.; Castaneda-Sceppa, C. Physical activity and public health in older adults: Recommendation from the American College of Sports Medicine and the American Heart Association. Circulation 2007, 116, 1094–1105.
44. Chodzko-Zajko, W.J.; Proctor, D.N.; Fiatarone Singh, M.A.; Minson, C.T.; Nigg, C.R.; Salem, G.J.; Skinner, J.S. American College of Sports Medicine position stand. Exercise and physical activity for older adults. Med. Sci. Sports Exerc. 2009, 41, 1510–1530.
45. Garcia-Aymerich, J.; Lange, P.; Benet, M.; Schnohr, P.; Anto, J.M. Regular physical activity reduces hospital admission and mortality in chronic obstructive pulmonary disease: A population based cohort study. Thorax 2006, 61, 772–778.
46. Waschki, B.; Kirsten, A.; Holz, O.; Muller, K.C.; Meyer, T.; Watz, H.; Magnussen, H. Physical activity is the strongest predictor of all-cause mortality in patients with COPD: A prospective cohort study. Chest 2011, 140, 331–342.
47. Hupin, D.; Roche, F.; Gremeaux, V.; Chatard, J.C.; Oriol, M.; Gaspoz, J.M.; Barthelemy, J.C.; Edouard, P. Even a low-dose of moderate-to-vigorous physical activity reduces mortality by 22% in adults aged 60 years: A systematic review and meta-analysis. Br. J. Sports Med. 2015, 49, 1262–1267.
48. Warburton, D.E.; Nicol, C.W.; Bredin, S.S. Health benefits of physical activity: The evidence. Can. Med. Assoc. J. 2006, 174, 801–809.
49. Wen, C.P.; Wai, J.P.; Tsai, M.K.; Yang, Y.C.; Cheng, T.Y.; Lee, M.C.; Chan, H.T.; Tsao, C.K.; Tsai, S.P.; Wu, X. Minimum amount of physical activity for reduced mortality and extended life expectancy: A prospective cohort study. Lancet 2011, 378, 1244–1253.
50. Vainshelboim, B.; Oliveira, J.; Fox, B.D.; Adir, Y.; Ollech, J.E.; Kramer, M.R. Physiological Profile and Limitations in Exercise in Idiopathic Pulmonary Fibrosis. J. Cardiopulm. Rehabil. Prev. 2016, 36, 270–278.
51. Lee, S.H.; Shim, H.S.; Cho, S.H.; Kim, S.Y.; Lee, S.K.; Son, J.Y.; Jung, J.Y.; Kim, E.Y.; Lim, J.E.; Lee, K.J.; et al. Prognostic factors for idiopathic pulmonary fibrosis: Clinical, physiologic, pathologic, and molecular aspects. Sarcoidosis Vasc. Diffuse Lung Dis. 2011, 28, 102–112.
52. Helmerhorst, H.J.; Brage, S.; Warren, J.; Besson, H.; Ekelund, U. A systematic review of reliability and objective criterion-related validity of physical activity questionnaires. Int. J. Behav. Nutr. Phys. Act. 2012, 9, 103.
53. Gaunaurd, I.A.; Gomez-Marin, O.W.; Ramos, C.F.; Sol, C.M.; Cohen, M.I.; Cahalin, L.P.; Cardenas, D.D.; Jackson, R.M. Physical activity and quality of life improvements of patients with idiopathic pulmonary fibrosis completing a pulmonary rehabilitation program. Respir. Care 2014, 59, 1872–1879.
54. Vainshelboim, B.; Fox, B.D.; Kramer, M.R.; Izhakian, S.; Gershman, E.; Oliveira, J. Short-Term Improvement in Physical Activity and Body Composition After Supervised Exercise Training Program in Idiopathic Pulmonary Fibrosis. Arch. Phys. Med. Rehabil. 2016, 97, 788–797.